Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-27 @ 12:48 AM
Study NCT ID:
NCT02280434
Status:
COMPLETED
Last Update Posted:
2016-11-03
First Post:
2014-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Sponsor:
Connect Biopharm LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CBP-307AU001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None